MedTrace Logo

Sickle Cell Anemia Screening and Prevention in Northern Israel

NCT00735488 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 69

Last updated 2015-09-01

No results posted yet for this study

Summary

Since 1987, a screening for β Thalassemia in pregnant women is carried on in northern Israel, and from 1999 all the samples were tested also for Hgb S, Hgb C, Hgb D, Hgb O Arab and others.

In this study, the investigators intend to summarize the results of this preventive program aiming to detect couples at risk for having offspring with Thalassemia or SCA, the compliance regard to genetic counseling and prenatal diagnosis and the incidence of new affected babies born.

Conditions

Interventions

OTHER

Observational

Summary of data

Sponsors & Collaborators

  • Ministry of Health, Israel

    collaborator OTHER_GOV

  • HaEmek Medical Center, Israel

    lead OTHER

Principal Investigators

  • Ariel Koren, MD · Pediatric Hematology Unit - Ha'Emek Medical Center - Afula - 18101 - Israel

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-05-31
Primary Completion
2009-03-31
Completion
2009-03-31

Countries

  • Israel

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00735488 on ClinicalTrials.gov